Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas. - Wikidata - awgldk - TriplyDB

Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.

Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.

http://www.wikidata.org/entity/Q42489894

about

The Justy mutant mouse strain produces a spontaneous murine model of salivary gland cancer with myoepithelial and basal cell differentiation Salivary acinic cell carcinoma: reappraisal and update.Intratumoral delivery of recombinant vaccinia virus encoding for ErbB2/Neu inhibits the growth of salivary gland carcinoma cells Afatinib and its encapsulated polymeric micelles inhibits HER2-overexpressed colorectal tumor cell growth in vitro and in vivo High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma.Human Epidermal Growth Factor Receptor 2 (HER2/neu) in Salivary Gland Carcinomas: A Review of Literature.Correlation between apparent diffusion coefficients and HER2 status in gastric cancers: pilot study.Primary Pulmonary Mucoepidermoid Carcinoma: Histopathological and Moleculargenetic Studies of 26 Cases.Molecular genetic studies on EGFR, KRAS, BRAF, ALK, PIK3CA, PDGFRA, and DDR2 in primary pulmonary adenoid cystic carcinoma.Breast metastasis of salivary duct carcinoma in a patient: a case report.Tissue microarray construction for salivary gland tumors study.Salivary mucoepidermoid carcinoma revisited.Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis.A low percentage of HER-2 amplification whereas indicates poor prognosis in salivary carcinoma ex pleomorphic adenoma: a study of 140 cases.Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).Programmed death ligand-1 expression is associated with poor disease free survival in salivary gland carcinomas.Targeted Approaches Applied to Uncommon Diseases: A Case of Salivary Duct Carcinoma Metastatic to the Brain Treated with the Multikinase Inhibitor Neratinib.Utility of Immunohistochemistry and ETV6 (12p13) Gene Rearrangement in Identifying Secretory Carcinoma of Salivary Gland among Previously Diagnosed Cases of Acinic Cell Carcinoma.Expression of Hormone Receptors and HER-2 in Benign and Malignant Salivary Gland Tumors.Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands.Significant and durable clinical benefit from trastuzumab in 2 patients with HER2-amplified salivary gland cancer and a review of the literature.Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study.Cutaneous adnexal adenocarcinoma with exquisite sensitivity to trastuzumab.Assessment of protein expression and gene status of human epidermal growth factor receptor (HER) family molecules in ameloblastomas.Immunohistochemical and molecular profile of salivary gland cancer in children.Mutation analysis of the EGFR pathway genes, EGFR, RAS, PIK3CA, BRAF, and AKT1, in salivary gland adenoid cystic carcinoma.Polyethylene glycol-conjugated HER2-targeted peptides as a nuclear imaging probe for HER2-overexpressed gastric cancer detection in vivo.

P2860

Q28507071-7C26BF52-1910-4005-A5FC-2253F3EDCFB5 Q30252000-60B70048-2E8F-4B0C-B609-274C8E33CC90 Q33645792-61847387-545A-4A96-BD11-2F4CC04AE4A1 Q34104079-643A774F-3111-4C47-909B-0772D6C8ACCD Q34436470-316AEA9A-55ED-4A59-8B11-5B115266FAFE Q35230643-2ED8CF0B-066F-439B-8930-B9AD636EC234 Q35815603-6B2027B9-BC2E-4EA4-A23B-E4CED7F772C3 Q35843530-0B509CF7-C7B8-416C-9A8D-AEDA0D65BCDC Q36063032-D82AF1B7-619B-40ED-B7B6-A7F2AE322CB0 Q36493317-1E1D64E6-4289-4498-8FF1-36FF8FE764CE Q36544198-83578A13-0B0F-407E-A50F-821C71E85151 Q38207529-5213EF73-4ADF-4ADD-9282-C41A5C12DE6F Q38614842-D4D7B355-1309-4AC5-9F6B-4EFB456A9CDE Q38841254-DA61606A-AA3E-4132-81A3-C684DA5EEA68 Q39012625-75D1721F-BF3D-49CB-B020-AB7B96B56323 Q40783341-9045C3C6-B613-4930-BCBB-16158DFA25FC Q41601105-2983E64D-9618-486D-AC11-3A0D40D44387 Q42290998-1607C806-40E8-458F-A62F-15E28531F87F Q45996599-E14E62DC-9DA3-4653-9751-365D47ADE5FD Q47259493-E52C2F1A-5C24-485E-9664-388F39199790 Q48123633-5B399660-2767-4C39-BE3A-C801036812A4 Q48170512-23BF7B06-7C40-4DC0-8901-A65D84AF0E9D Q51127479-4656D64C-94DC-417C-846F-8E48512212AA Q53126969-1A0EDDDD-A17E-4FED-8123-075000EA065F Q54129929-A8514555-98D7-4F08-8C0E-F7865EBE6CE2 Q55004879-CF61BA0A-E632-4E95-A298-2E7B6F89218C Q55286461-B96A3F0B-9408-451A-9BB3-56B8E78F9215

P2860

Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.

http://www.wikidata.org/entity/Q42489894

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.

@en

type

label

Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.

@en

prefLabel

Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.

@en

P1433

Q42489894-38AEA0EC-ED05-45C7-9862-675EEBD2AB51

P1476

Q42489894-974619D3-6007-4167-917C-F91DF1A283C5

P2093

Q42489894-0A1B6228-72CA-4A01-8268-B32DAAD8F05F

Q42489894-3A6734D9-5985-4408-A836-BE945D297741

Q42489894-5E8412B5-D513-417D-AC15-D6EAB31E9437

Q42489894-711A82CA-4277-4D23-9363-D27CAE1D3892

Q42489894-B9AA7CF6-4D40-430D-8403-F20CE583057A

Q42489894-C4BED953-7C63-49C8-B334-98E258541635

Q42489894-D2870453-B43A-4171-B5D7-D4EE142D06B6

Q42489894-EB895803-3FB9-4319-BC05-3B06B90ADABD

Q42489894-EF6342E5-F28D-439F-AD56-BF5B60D5EBEB

Q42489894-F1B6FD33-CA9D-48B1-8DD8-9FBB6AD4A815

P304

Q42489894-E0D0971F-4729-4C70-AA47-53C52707D251

P31

Q42489894-6A35F62D-524A-4ED7-8DA3-720C1B5AC9B7

P356

Q42489894-41C63686-84E0-4EB1-9E90-B2FAD8D6B01E

P433

Q42489894-3B6733FA-3CF7-4EF0-9932-CED4CB219EF3

P478

Q42489894-FD811CE9-4F62-41DE-BB15-EAF23848C09A

P577

Q42489894-5119B8B0-5083-456C-91A4-DAE4C286546A

P698

Q42489894-830B8B0A-8436-4CCE-9B35-919E8378F74E

P356

PAT.0B013E3283484A60

P1433

P1476

Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.

@en

P2093

Adrian Münscher

http://www.w3.org/2001/XMLSchema#string

Alexander Gnoss

http://www.w3.org/2001/XMLSchema#string

Carsten Bokemeyer

http://www.w3.org/2001/XMLSchema#string

Guido Sauter

http://www.w3.org/2001/XMLSchema#string

Linn Gravert

http://www.w3.org/2001/XMLSchema#string

Maren Reiff

http://www.w3.org/2001/XMLSchema#string

Maria-Christina Tsourlakis

http://www.w3.org/2001/XMLSchema#string

Rainald Knecht

http://www.w3.org/2001/XMLSchema#string

Till Sebastian Clauditz

http://www.w3.org/2001/XMLSchema#string

Waldemar Wilczak

http://www.w3.org/2001/XMLSchema#string

P304

459-464

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/PAT.0B013E3283484A60

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21670724

http://www.w3.org/2001/XMLSchema#string